|
|
|
24.11.25 - 17:00
|
Embla Medical hf: Transactions in relation to Share Buyback Program (Cision)
|
|
|
Announcement no. 54/2025
24 November 2025
Reykjavik, Iceland/Copenhagen, Denmark, 24 November 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025.
During the period 17 November to 21 November 2025 Embla Medical has acquired 23,456 shares under the Program at the average price of DKK 33.41. Following the transactions below, the Company holds 2,558,929 shares, corresponding to 0.59% of...
|
|
|
17.11.25 - 17:00
|
Embla Medical hf: Transactions in relation to Share Buyback Program (Cision)
|
|
|
Announcement no. 53/2025
17 November 2025
Reykjavik, Iceland/Copenhagen, Denmark, 17 November 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025.
During the period 10 November to 14 November 2025 Embla Medical has acquired 37,538 shares under the Program at the average price of DKK 34.53. Following the transactions below, the Company holds 2,538,022 shares, corresponding to 0.59% of...
|
|
|
10.11.25 - 17:02
|
Embla Medical hf: Transactions in relation to Share Buyback Program (Cision)
|
|
|
Announcement no. 52/2025
10 November 2025
Reykjavik, Iceland/Copenhagen, Denmark, 10 November 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025.
During the period 3 November to 7 November 2025 Embla Medical has acquired 50,692 shares under the Program at the average price of DKK 34.29. Following the transactions below, the Company holds 2,500,484 shares, corresponding to 0.58% of...
|
|
|
|
|
03.11.25 - 17:06
|
Embla Medical hf: Transactions in relation to Share Buyback Program (Cision)
|
|
|
Announcement no. 51/2025
3 November 2025
Reykjavik, Iceland/Copenhagen, Denmark, 3 November 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025.
During the period 27 October to 31 October 2025 Embla Medical has acquired 59,000 shares under the Program at the average price of DKK 33.79. Following the transactions below, the Company holds 2,449,792 shares, corresponding to 0.57% of the...
|
|
|
27.10.25 - 17:06
|
Embla Medical hf: Transactions in relation to Share Buyback Program (Cision)
|
|
|
Announcement no. 50/2025
27 October 2025
Reykjavik, Iceland/Copenhagen, Denmark, 27 October 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025.
During the period 20 October to 24 October 2025 Embla Medical has acquired 50,000 shares under the Program at the average price of DKK 32.65. Following the transactions below, the Company holds 2,397,313 shares, corresponding to 0.56% of the...
|
|
|
|
|
|
|
21.10.25 - 07:42
|
Embla Medical hf: Interim Report Q3 2025 (PR Newswire)
|
|
|
COPENHAGEN, Denmark, Oct. 21, 2025 /PRNewswire/ -- Announcement no. 49/2025 Interim report Q3 2025 21 October 2025 Sveinn Sölvason, President and CEO, comments: "Sales in Q3 2025 amounted to USD 237 million, representing 11% reported growth, of which 7% was organic. Growth picked up in......
|
|
|
21.10.25 - 07:33
|
Embla Medical hf: Interim Report Q3 2025 (PR Newswire)
|
|
|
COPENHAGEN, Denmark, Oct. 21, 2025 /PRNewswire/ -- Announcement no. 49/2025 Interim report Q3 2025 21 October 2025 Sveinn Sölvason, President and CEO, comments: "Sales in Q3 2025 amounted to USD 237 million, representing 11% reported growth, of which 7% was organic. Growth picked up in......
|
|
|
21.10.25 - 07:00
|
Embla Medical hf: Interim Report Q3 2025 (Cision)
|
|
|
Announcement no. 49/2025
Interim report Q3 2025
21 October 2025
Sveinn Sölvason, President and CEO, comments:
“Sales in Q3 2025 amounted to USD 237 million, representing 11% reported growth, of which 7% was organic. Growth picked up in the third quarter as expected, driven by double-digit growth in Prosthetics & Neuro Orthotics. The solid momentum in EMEA continues and growth in Americas was strong following a soft start to the year, supported by our recently launched innovations such as Navii, Icon, and Pro-Flex Terra.
Sales in our Bracing & Supports and Patient Care...
|
|
|
20.10.25 - 17:01
|
Embla Medical hf: Transactions in relation to Share Buyback Program (Cision)
|
|
|
Announcement no. 48/2025
20 October 2025
Reykjavik, Iceland/Copenhagen, Denmark, 20 October 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025.
During the period 13 October to 17 October 2025 Embla Medical has acquired 63,656 shares under the Program at the average price of DKK 31.65. Following the transactions below, the Company holds 2,347,313 shares, corresponding to 0.55% of the...
|
|
|
13.10.25 - 17:01
|
Embla Medical hf: Transactions in relation to Share Buyback Program (Cision)
|
|
|
Announcement no. 47/2025
13 October 2025
Reykjavik, Iceland/Copenhagen, Denmark, 13 October 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025.
During the period 6 October to 10 October 2025 Embla Medical has acquired 75,000 shares under the Program at the average price of DKK 31.82. Following the transactions below, the Company holds 2,283,657 shares, corresponding to 0.53% of the...
|
|
|
06.10.25 - 17:01
|
Embla Medical hf: Transactions in relation to Share Buyback Program (Cision)
|
|
|
Announcement no. 46/2025
6 October 2025
Reykjavik, Iceland/Copenhagen, Denmark, 6 October 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025.
During the period 29 September to 3 October 2025 Embla Medical has acquired 92,000 shares under the Program at the average price of DKK 32.08. Following the transactions below, the Company holds 2,208,657 shares, corresponding to 0.51% of the...
|
|
|
03.10.25 - 08:06
|
Embla Medical hf: Conference call details for Q3 2025 (Cision)
|
|
|
Reykjavik, Iceland/Copenhagen, Denmark, 3 October 2025. Embla Medical (Nasdaq Copenhagen: EMBLA) will publish its Q3 2025 Report on 21 October 2025 at 7:00 CET. A conference call will be hosted on the same day at 9:00 CET / 7:00 GMT / 3:00am EST.
The event will be hosted by Sveinn Solvason, President and CEO, and G. Arna Sveinsdottir, CFO. The call will include a review of the quarterly results and will be held in English.
Slides used in the presentation will be made available on the company website at the following link: https://www.emblamedical.com/investors
To participate in the...
|
|
|
29.09.25 - 17:01
|
Embla Medical hf: Transactions in relation to Share Buyback Program (Cision)
|
|
|
Announcement no. 45/2025
29 September 2025
Reykjavik, Iceland/Copenhagen, Denmark, 29 September 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025.
During the period 22 September to 26 September 2025 Embla Medical has acquired 75,000 shares under the Program at the average price of DKK 33.19. Following the transactions below, the Company holds 2,116,,657 shares, corresponding to 0....
|
|
|
22.09.25 - 17:01
|
Embla Medical hf: Transactions in relation to Share Buyback Program (Cision)
|
|
|
Announcement no. 44/2025
22 September 2025
Reykjavik, Iceland/Copenhagen, Denmark, 22 September 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025.
During the period 15 September to 19 September 2025 Embla Medical has acquired 60,000 shares under the Program at the average price of DKK 32.29. Following the transactions below, the Company holds 2,041,657 shares, corresponding to 0.47%...
|
|
|
15.09.25 - 17:01
|
Embla Medical hf: Transactions in relation to Share Buyback Program (Cision)
|
|
|
Announcement no. 43/2025
15 September 2025
Reykjavik, Iceland/Copenhagen, Denmark, 15 September 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025.
During the period 8 September to 12 September 2025 Embla Medical has acquired 25,789 shares under the Program at the average price of DKK 30.62. Following the transactions below, the Company holds 1,981,657 shares, corresponding to 0.46%...
|
|
|
09.09.25 - 17:01
|
Embla Medical hf: Transactions in relation to Share Buyback Program (Cision)
|
|
|
Announcement no. 42/2025
9 September 2025
Reykjavik, Iceland/Copenhagen, Denmark, 9 September 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025.
During the period 1 September to 5 September 2025 Embla Medical has acquired 29,109 shares under the Program at the average price of DKK 31.93. Following the transactions below, the Company holds 1,955,868 shares, corresponding to 0.45% of...
|
|
|
03.09.25 - 20:36
|
Embla Medical hf: Embla Medical completes share issue following closing of majority share investment in Streifeneder ortho.production GmbH (Cision)
|
|
|
Announcement no. 41/2025
3 September 2025
Reference is made to announcement no. 39/2025 published on 29 August 2025 (Embla Medical closes the majority share investment in Streifeneder ortho.production GmbH).
Reykjavik, Iceland/Copenhagen, Denmark, 3 September 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced that in connection with the majority investment in Streifeneder ortho.production, the Board of Directors of Embla Medical resolved to utilize the authorization in Article 5, paragraph 1, of the Articles...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
